$FORL
Four Leaf Acquisition Corp Stock $forl

$forl Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000119312524200695 Filed on August 14, 2024

Income Statement

Concept	2024 Q2
Revenue	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$424.0K
YoY Change	69.61%
Operating Profit	-$424.0K
YoY Change	67.51%
Interest Expense	$737.3K
YoY Change	-12.22%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$313.3K
YoY Change	-46.64%
Income Tax	$146.7K
% Of Pretax Income	46.81%
Net Earnings	$166.7K
YoY Change	-63.22%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.03
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$860.00
YoY Change	-99.43%
Cash & Equivalents	$862.00
Short-Term Investments
Other Short-Term Assets	$55.50K
YoY Change	-7.5%
Inventory
Prepaid Expenses	$55.50K
Receivables
Other Receivables
Total Short-Term Assets	$56.36K
YoY Change	-72.66%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$29.41M
YoY Change	-47.99%
Other Assets
YoY Change
Total Long-Term Assets	$29.41M
YoY Change	-48.0%
TOTAL ASSETS
Total Short-Term Assets	$56.36K
Total Long-Term Assets	$29.41M
Total Assets	$29.47M
YoY Change	-48.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$724.2K
YoY Change	193.49%
Accrued Expenses	$399.4K
YoY Change	166.25%
Deferred Revenue
YoY Change
Short-Term Debt	$1.379M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.016M
YoY Change	457.89%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$1.897M
YoY Change	-0.14%
Total Long-Term Liabilities	$1.897M
YoY Change	-0.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.016M
Total Long-Term Liabilities	$1.897M
Total Liabilities	$4.913M
YoY Change	101.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.478M
YoY Change	-1208.38%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.478M
YoY Change
Total Liabilities & Shareholders Equity	$29.47M
YoY Change	-48.09%

Cashflow Statement

Concept	2024 Q2
OPERATING ACTIVITIES
Net Income	$166.7K
YoY Change	-63.22%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$741.2K
YoY Change	641.18%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$30.69M
YoY Change
Cash From Investing Activities	$30.69M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-29.95M
YoY Change	74773.4%
NET CHANGE
Cash From Operating Activities	-741.2K
Cash From Investing Activities	30.69M
Cash From Financing Activities	-29.95M
Net Change In Cash	-4.380K
YoY Change	-96.87%
FREE CASH FLOW
Cash From Operating Activities	-$741.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: "Times New Roman";text-indent: 0px;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Significant assumptions include the fair value of the Company’s Public Warrants and Representative Shares, at their issuance dates, the valuation of the over-allotment option provided to the underwriters and the excise tax liability in connection with redemption of Class A common stock that occurred at the 2024 Special Meeting. Actual results could differ from those estimates. </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;text-indent: 0px;"> </div>
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001936255
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	Four Leaf Acquisition Corporation
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity File Number EntityFileNumber	001-41646
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-1178935
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4546 El Camino Real B10 #715
	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Altos
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94022
	dei	City Area Code CityAreaCode	650
	dei	Local Phone Number LocalPhoneNumber	720-5626
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://www.fourleaf.com/20240630#ChangeInFairValueOfOverallotmentOptionLiability
	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://www.fourleaf.com/20240630#ChangeInFairValueOfOverallotmentOptionLiability
CY2023Q2	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://www.fourleaf.com/20240630#ChangeInFairValueOfOverallotmentOptionLiability
CY2024Q2	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://www.fourleaf.com/20240630#ChangeInFairValueOfOverallotmentOptionLiability
CY2024Q2	us-gaap	Cash Cash	862
CY2023Q4	us-gaap	Cash Cash	10622
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	55500
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	49842
CY2024Q2	us-gaap	Assets Current AssetsCurrent	56362
CY2023Q4	us-gaap	Assets Current AssetsCurrent	60464
CY2024Q2	forlu	Marketable Securities Held In Trust Account MarketableSecuritiesHeldInTrustAccount	29414956
CY2023Q4	forlu	Marketable Securities Held In Trust Account MarketableSecuritiesHeldInTrustAccount	58063737
CY2024Q2	us-gaap	Assets Assets	29471318
CY2023Q4	us-gaap	Assets Assets	58124201
CY2024Q2	forlu	Accruedofferingcostscurrent Accruedofferingcostscurrent	97440
CY2023Q4	forlu	Accruedofferingcostscurrent Accruedofferingcostscurrent	97440
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	724206
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	402663
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	122180
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	62180
CY2024Q2	forlu	Convertible Note Related Party Current ConvertibleNoteRelatedPartyCurrent	1379100
CY2023Q4	forlu	Convertible Note Related Party Current ConvertibleNoteRelatedPartyCurrent	272000
CY2024Q2	forlu	Deferred Credit Insurance Fee Current DeferredCreditInsuranceFeeCurrent	191250
CY2023Q4	forlu	Deferred Credit Insurance Fee Current DeferredCreditInsuranceFeeCurrent	191250
CY2024Q2	forlu	Excise Tax Payable Current ExciseTaxPayableCurrent	301943
CY2023Q4	forlu	Excise Tax Payable Current ExciseTaxPayableCurrent	0
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	199562
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	443990
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3015681
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1469523
CY2024Q2	forlu	Deferred Underwriting Fee Payable Noncurrent DeferredUnderwritingFeePayableNoncurrent	1897350
CY2023Q4	forlu	Deferred Underwriting Fee Payable Noncurrent DeferredUnderwritingFeePayableNoncurrent	1897350
CY2024Q2	us-gaap	Liabilities Liabilities	4913031
CY2023Q4	us-gaap	Liabilities Liabilities	3366873
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	29036234
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	56067420
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4478088
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1310233
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-4477947
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1310092
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29471318
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	58124201
CY2024Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	424028
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	253135
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	876445
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	311519
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-424028
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-253135
	us-gaap	Operating Income Loss OperatingIncomeLoss	-876445
	us-gaap	Operating Income Loss OperatingIncomeLoss	-311519
CY2024Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	737335
CY2023Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	666505
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1495275
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	728325
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-173764
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-134583
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	313307
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	587134
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	618830
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	551389
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	146651
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	134023
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	321572
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	141062
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	166656
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	453111
	us-gaap	Net Income Loss NetIncomeLoss	297258
	us-gaap	Net Income Loss NetIncomeLoss	410327
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1310092
CY2024Q1	forlu	Accretion Of Class A Ordinary Shares To Accreted Value AccretionOfClassAOrdinarySharesToAccretedValue	-1439127
CY2024Q1	forlu	Temporary Equity Adjustments On Account Of Dividend And Interest TemporaryEquityAdjustmentsOnAccountOfDividendAndInterest	-552520
CY2024Q1	forlu	Temporary Equity Adjustment To Redemption Value Due To Extension Payment TemporaryEquityAdjustmentToRedemptionValueDueToExtensionPayment	-542100
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	130602
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-3713237
CY2024Q2	forlu	Temporary Equity Adjustments On Account Of Dividend And Interest TemporaryEquityAdjustmentsOnAccountOfDividendAndInterest	-554423
CY2024Q2	forlu	Temporary Equity Adjustment To Redemption Value Due To Extension Payment TemporaryEquityAdjustmentToRedemptionValueDueToExtensionPayment	-75000
CY2024Q2	forlu	Stockholders Equity Adjustment Excise Tax Payable StockholdersEquityAdjustmentExciseTaxPayable	-301943
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	166656
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-4477947
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	18694
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	270520
CY2023Q1	forlu	Accretion Of Class A Ordinary Shares To Accreted Value AccretionOfClassAOrdinarySharesToAccretedValue	-314307
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-42784
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	4636963
CY2023Q2	forlu	Accretion Of Class A Ordinary Shares To Accreted Value AccretionOfClassAOrdinarySharesToAccretedValue	-2231134
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	453111
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2858940
	us-gaap	Net Income Loss NetIncomeLoss	297258
	us-gaap	Net Income Loss NetIncomeLoss	410327
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1495275
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	728325
	forlu	Change In Fair Value Of Overallotment Option Liability ChangeInFairValueOfOverallotmentOptionLiability	0
	forlu	Change In Fair Value Of Overallotment Option Liability ChangeInFairValueOfOverallotmentOptionLiability	-134583
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	5658
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	50417
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	321544
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	246761
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	60000
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	5000
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-244428
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	141062
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1066559
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-110175
	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	0
	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	55836300
	forlu	Extension Payments Deposited Into Trust Account ExtensionPaymentsDepositedIntoTrustAccount	617100
	forlu	Extension Payments Deposited Into Trust Account ExtensionPaymentsDepositedIntoTrustAccount	0
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	30761155
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	0
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	30144055
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55836300
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1107100
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0
	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	30194356
	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	84000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	395500
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	54210000
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3577000
	forlu	Payment Of Offering Costs On Public Units PaymentOfOfferingCostsOnPublicUnits	0
	forlu	Payment Of Offering Costs On Public Units PaymentOfOfferingCostsOnPublicUnits	1382072
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-29087256
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	56093428
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-9760
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	146953
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10622
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1280
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	862
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	148233
	forlu	Remeasurement Of Class A Shares Subject To Possible Redemption RemeasurementOfClassASharesSubjectToPossibleRedemption	3163170
	forlu	Remeasurement Of Class A Shares Subject To Possible Redemption RemeasurementOfClassASharesSubjectToPossibleRedemption	2545441
	forlu	Deferred Underwriting Commissions. DeferredUnderwritingCommissions.	0
	forlu	Deferred Underwriting Commissions. DeferredUnderwritingCommissions.	1897350
	us-gaap	Stock Issued1 StockIssued1	0
	us-gaap	Stock Issued1 StockIssued1	270515
	forlu	Offering Costs Included In Accrued Offering Costs OfferingCostsIncludedInAccruedOfferingCosts	0
	forlu	Offering Costs Included In Accrued Offering Costs OfferingCostsIncludedInAccruedOfferingCosts	150552
	forlu	Excise Tax Liability Incurred During The Period ExciseTaxLiabilityIncurredDuringThePeriod	301943
	forlu	Excise Tax Liability Incurred During The Period ExciseTaxLiabilityIncurredDuringThePeriod	0
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	54210000
CY2023Q1	forlu	Transaction Costs TransactionCosts	4019087
CY2023Q1	forlu	Deferred Underwriting Fees Payable Noncurrent DeferredUnderwritingFeesPayableNoncurrent	2710500
CY2023Q1	forlu	Payment Of Deferred Underwriting Fees PaymentOfDeferredUnderwritingFees	813150
CY2023Q1	forlu	Other Offering Costs OtherOfferingCosts	1038067
CY2023Q1	us-gaap	Cash Cash	974028
CY2023Q1	forlu	Term Of Restricted Investments TermOfRestrictedInvestments	P185D
CY2024Q2	us-gaap	Minimum Net Worth Required For Compliance MinimumNetWorthRequiredForCompliance	5000001
CY2024Q2	forlu	Percentage Of Shares Sold In Ipo That Can Be Transferred Without Any Restriction PercentageOfSharesSoldInIpoThatCanBeTransferredWithoutAnyRestriction	0.15
CY2024Q2	forlu	Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination	1
CY2024Q1	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	542100
CY2024Q2	forlu	Number Of Months By Which Time Limit Could Be Extended For Consummating Business Combination NumberOfMonthsByWhichTimeLimitCouldBeExtendedForConsummatingBusinessCombination	P12M
CY2024Q2	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	30200000
CY2024Q2	forlu	Per Share Withdrawn From The Trust Account PerShareWithdrawnFromTheTrustAccount	10.97
CY2024Q2	forlu	Extension Payments Deposited Into Trust Account ExtensionPaymentsDepositedIntoTrustAccount	75000
CY2024Q2	us-gaap	Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities	100000
CY2024Q2	forlu	Amount Per Share To Be Maintained In The Trust Account AmountPerShareToBeMaintainedInTheTrustAccount	10.3
CY2024Q2	us-gaap	Cash Cash	862
CY2024Q2	forlu	Working Capital Deficit WorkingCapitalDeficit	2579796
	forlu	Accrued Excise Tax Liability AccruedExciseTaxLiability	301944
CY2024Q2	forlu	Accrued Excise Tax Liability AccruedExciseTaxLiability	301944
CY2024Q2	forlu	Excise Tax Liability ExciseTaxLiability	301944
CY2023Q4	forlu	Excise Tax Liability ExciseTaxLiability	0
CY2024Q2	forlu	Proceeds From Trust Account To Pay Tax Obligations ProceedsFromTrustAccountToPayTaxObligations	566800
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: "Times New Roman";text-indent: 0px;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts. </div>
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	forlu	Percentage Of Common Stock On Conversion Of Shares PercentageOfCommonStockOnConversionOfShares	0.20
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0
CY2024Q2	us-gaap	Share Price SharePrice	0.81
CY2024Q2	forlu	Aggregate Grant Date Fair Value Of The Awards AggregateGrantDateFairValueOfTheAwards	40500
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	40500
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.47
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.228
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.484
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.256
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.47
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.484
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2024Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.228
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.256
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	22012
CY2024Q2	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0
CY2023Q2	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0
	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0

Files In Submission

Name	View Source	Status
0001193125-24-200695-index-headers.html	Edgar Link	pending
0001193125-24-200695-index.html	Edgar Link	pending
0001193125-24-200695.txt	Edgar Link	pending
0001193125-24-200695-xbrl.zip	Edgar Link	pending
d880718d10q.htm	Edgar Link	pending
d880718dex101.htm	Edgar Link	pending
d880718dex102.htm	Edgar Link	pending
d880718dex103.htm	Edgar Link	pending
d880718dex104.htm	Edgar Link	pending
d880718dex311.htm	Edgar Link	pending
d880718dex312.htm	Edgar Link	pending
d880718dex321.htm	Edgar Link	pending
d880718dex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
forlu-20240630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
forlu-20240630_def.xml	Edgar Link	unprocessable
forlu-20240630_cal.xml	Edgar Link	unprocessable
forlu-20240630_lab.xml	Edgar Link	unprocessable
forlu-20240630_pre.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
d880718d10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FORL
Four Leaf Acquisition Corp Stock $forl

2024 Q2 Form 10-Q Financial Statement

#000119312524200695 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FORL Four Leaf Acquisition Corp Stock $forl

2024 Q2 Form 10-Q Financial Statement

#000119312524200695 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FORL
Four Leaf Acquisition Corp Stock $forl